Anti-myeloma potential of ruxolitinib in co-existing JAK2V617F-positive smouldering myeloma and polycythaemia vera.

Holly LeeSylvia McCullochEtienne MaheMona ShafeyFariborz Rashid-KolvearFaisal KhanDwip PrajapatiPaola NeriPeter DugganJason TayNizar BahlisVictor H Jimenez-Zepeda

Published in: British journal of haematology (2020)

Keyphrases

multiple myeloma
newly diagnosed
human health
risk assessment
climate change